You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 45 No. 12, December 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLE
 This Article
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Polyneuropathies associated with IgM monoclonal gammopathies

J. J. Kelly, L. S. Adelman, E. Berkman and I. Bhan
Department of Neurology, Tufts Medical School, Boston.

We studied ten patients with IgM monoclonal gammopathies. Five had M proteins that reacted with myelin-associated glycoprotein (MAG) and five had no recognizable antinerve activity. The neuropathy in the MAG-reactive patients was homogeneous by clinical and laboratory analysis, while the neuropathy in the MAG-nonreactive patients varied considerably. Both groups responded well to immunosuppressive therapy, which lowered the concentration of the serum M protein. The homogeneity of the MAG-reactive patients and their response to sustained lowering of the M protein levels support the concept that the IgM M protein directly damages nerve fibers and is the proximate cause of the polyneuropathy.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cladribine in the treatment of IgM paraproteinemic polyneuropathy
Ghosh et al.
Neurology 2002;59:1290-1291.
FULL TEXT  

Neuropathy and IgM M-proteins: Prognostic value of antibodies to MAG, SGPG, and sulfatide
Eurelings et al.
Neurology 2001;56:228-233.
ABSTRACT | FULL TEXT  

Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies
Nobile-Orazio et al.
Brain 2000;123:710-717.
ABSTRACT | FULL TEXT  

Distal acquired demyelinating symmetric neuropathy
Katz et al.
Neurology 2000;54:615-615.
ABSTRACT | FULL TEXT  

Successful treatment of IgM paraproteinaemic neuropathy with fludarabine
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 1999;66:575-580.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.